Literature DB >> 7657547

Development of grating acuity in children treated for unilateral or bilateral congenital cataract.

T L Lewis1, D Maurer, H P Brent.   

Abstract

PURPOSE: To study the development of grating acuity in children treated for dense congenital unilateral or bilateral cataract and to examine how variations in treatment affect grating acuity during early childhood.
METHODS: The authors used optokinetic nystagmus (OKN), preferential looking (PL), or both to measure the grating acuity of children treated for congenital cataract in one eye (n = 63) or both eyes (n = 77) whenever possible from the time of treatment until 3 years of age. At each age, the authors compared patients' monocular acuity to that of children with no history of eye disorders.
RESULTS: The OKN acuity of treated eyes did not improve with age and was abnormal by 12 months of age. In contrast, PL acuity improved with age, and acuity of most treated eyes was not outside normal limits until 24 to 30 months of age. Nonetheless, at 12 months and at 3 years of age, PL acuity correlated significantly with age at treatment in children who had bilateral cataract. In children who had unilateral cataract, PL acuity correlated significantly with the number of hours per day the good eye had been patched since treatment. Children whose good eye was patched fewer than 3 hours per day did significantly worse than children treated at a comparable age for bilateral congenital cataract. However, children whose good eye was patched at least 3 hours per day had PL acuities similar to those of children treated at a comparable age for bilateral congenital cataract.
CONCLUSIONS: Children treated for congenital cataract show deficits in grating acuity, with the deficit apparent earlier in OKN acuity than in PL acuity. At least by 1 year of age, visual development has begun to be influenced by the age at treatment and, in children treated for unilateral cataract, by patching of the good eye.

Entities:  

Mesh:

Year:  1995        PMID: 7657547

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

Review 1.  Should we aggressively treat unilateral congenital cataracts?

Authors:  D Taylor; K W Wright; L Amaya; L Cassidy; K Nischal; I Russell-Eggitt; S Lightman; P McCluskey
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

2.  A pilot randomized trial of contrast-rebalanced binocular treatment for deprivation amblyopia.

Authors:  Eileen E Birch; Reed M Jost; Serena X Wang; Krista R Kelly
Journal:  J AAPOS       Date:  2020-10-16       Impact factor: 1.220

3.  Adherence to occlusion therapy in the first six months of follow-up and visual acuity among participants in the Infant Aphakia Treatment Study (IATS).

Authors:  Carolyn D Drews-Botsch; Marianne Celano; Stacey Kruger; E Eugenie Hartmann
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-05       Impact factor: 4.799

4.  Motor skills of children with unilateral visual impairment in the Infant Aphakia Treatment Study.

Authors:  Marianne Celano; E Eugenie Hartmann; Lindreth G DuBois; Carolyn Drews-Botsch
Journal:  Dev Med Child Neurol       Date:  2015-06-17       Impact factor: 5.449

5.  Outcomes of the infantile cataract surgery: case series with a 5-year follow-up.

Authors:  Amirhooshang Beheshtnejad; Hesam Hashemian; Sajjad Kakaie; Alborz Mahdavi; Morteza Naderan
Journal:  Int Ophthalmol       Date:  2021-10-11       Impact factor: 2.031

6.  The effect of blur on cortical responses to global form and motion.

Authors:  Eliza A Burton; John Wattam-Bell; Gary S Rubin; Janette Atkinson; Oliver Braddick; Marko Nardini
Journal:  J Vis       Date:  2015       Impact factor: 2.240

Review 7.  Optical correction of aphakia in children.

Authors:  Alireza Baradaran-Rafii; Ebrahim Shirzadeh; Medi Eslani; Mitra Akbari
Journal:  J Ophthalmic Vis Res       Date:  2014-01

8.  Brief period of monocular deprivation drives changes in audiovisual temporal perception.

Authors:  Collins Opoku-Baah; Mark T Wallace
Journal:  J Vis       Date:  2020-08-03       Impact factor: 2.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.